Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases in Myanmar Artemisinin Resistance Containment Zones and Malaria Antibody Kinetic Analysis

NCT02708199 is registered in ClinicalTrials.gov with Department of Medical Research, Lower Myanmar as lead sponsor.

NCT NCT02708199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02708199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases in Myanmar Artemisinin Resistance Containment Zones and Malaria Antibody Kinetic Analysis
Lead sponsor
Department of Medical Research, Lower Myanmar
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
December 31, 2015
Enrollment
1,179 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic infection, increased drug resistance, malaria